Dodge & Cox — BMRN Trade History

Quarter-by-quarter changes in the BioMarin Pharmaceutical, Inc. position · CUSIP 09061G101
Currently held · 6.8 YearsFirst seen: 2019 Q4
QuarterFiledActivitySharesΔ SharesΔ %Value% Port.
2026 Q22026-08-13Add14,844,930283,171+1.9%$849.4M0.45%
2026 Q12026-05-14Reduce14,561,759-10,625-0.1%$822.6M0.45%
2025 Q42026-02-13Reduce14,572,384-114,417-0.8%$866.0M0.47%
2025 Q32025-11-13Reduce14,686,801-421,509-2.8%$795.4M0.43%
2025 Q22025-08-13Add15,108,310153,070+1.0%$830.5M0.47%
2025 Q12025-05-14Add14,955,240209,005+1.4%$1.06B0.60%
2024 Q42025-02-13Add14,746,235847,917+6.1%$969.3M0.56%
2024 Q32024-11-13Reduce13,898,318-32,175-0.2%$976.9M0.55%
2024 Q22024-08-13Reduce13,930,493-62,450-0.4%$1.15B0.69%
2024 Q12024-05-14Reduce13,992,943-1,120-0.0%$1.22B0.71%
2023 Q42024-02-22Reduce13,994,063-159,440-1.1%$1.35B0.86%
2023 Q32023-11-14Reduce14,153,503-136,800-1.0%$1.25B0.84%
2023 Q22023-08-14Reduce14,290,303-39,010-0.3%$1.24B0.83%
2023 Q12023-05-12Reduce14,329,313-54,350-0.4%$1.39B0.95%
2022 Q42023-02-14Reduce14,383,663-390,300-2.6%$1.49B1.02%
2022 Q32022-11-10Reduce14,773,963-233,100-1.6%$1.25B0.95%
2022 Q22022-08-12Reduce15,007,063-27,936-0.2%$1.24B0.86%
2022 Q12022-05-13Add15,034,999209,950+1.4%$1.16B0.70%
2021 Q42022-02-14Add14,825,0496,467+0.0%$1.31B0.81%
2021 Q32021-11-15Add14,818,582716,485+5.1%$1.15B0.75%
2021 Q22021-08-13Add14,102,0972,247,789+19.0%$1.18B0.77%
2021 Q12021-05-14Add11,854,3082,057,384+21.0%$895.1M0.64%
2020 Q42021-02-11Add9,796,9242,076,701+26.9%$859.1M0.68%
2020 Q32020-11-13Add7,720,2234,104,483+113.5%$587.4M0.54%
2020 Q22020-08-13Reduce3,615,740-326,768-8.3%$446.0M0.41%
2020 Q12020-05-14Reduce3,942,508-447,007-10.2%$333.1M0.36%
2019 Q42020-02-13New4,389,5154,389,515$371.1M0.28%
2019 Q32019-11-13
2019 Q22019-08-13
2019 Q12019-05-14
2018 Q42019-02-14
2018 Q32018-11-21
2018 Q22018-08-14
2018 Q12018-05-14
2017 Q42018-02-14
2017 Q32017-11-13
2017 Q22017-08-11
2017 Q12017-05-12
2016 Q42017-03-20
2016 Q32016-11-14

Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.